Aida Rashidi

1.9k total citations · 2 hit papers
27 papers, 1.3k citations indexed

About

Aida Rashidi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Aida Rashidi has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 12 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Aida Rashidi's work include Immune cells in cancer (11 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (6 papers). Aida Rashidi is often cited by papers focused on Immune cells in cancer (11 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (6 papers). Aida Rashidi collaborates with scholars based in United States, Russia and Mexico. Aida Rashidi's co-authors include Maciej S. Lesniak, Jason Miska, Yu Han, Aurora Lopez‐Rosas, Catalina Lee-Chang, Peng Zhang, Deepak Kanojia, Navdeep S. Chandel, Ting Xiao and Wojciech K. Panek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Aida Rashidi

27 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation

2022 216 citations Leah K. Billingham, Joshua S. Stoolman et al. Nature Immunology profile →
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

2023 139 citations Peng Zhang, Aida Rashidi et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aida Rashidi United States	19	644	489	387	248	202	27	1.3k
Catalina Lee-Chang United States	21	1.1k 1.8×	526 1.1×	739 1.9×	375 1.5×	275 1.4×	45	2.0k
Dorina Veliceasa United States	21	284 0.4×	775 1.6×	283 0.7×	146 0.6×	59 0.3×	28	1.4k
Pravin Kesarwani United States	21	390 0.6×	477 1.0×	266 0.7×	168 0.7×	52 0.3×	44	1.1k
Diana Moughon United States	8	655 1.0×	350 0.7×	507 1.3×	174 0.7×	59 0.3×	13	1.1k
Mariko Kawakami United States	23	657 1.0×	431 0.9×	416 1.1×	106 0.4×	64 0.3×	52	1.4k
Jae-Hung Shieh United States	20	334 0.5×	959 2.0×	352 0.9×	220 0.9×	57 0.3×	36	1.6k
Mahdi Abdoli Shadbad Iran	22	454 0.7×	558 1.1×	569 1.5×	50 0.2×	110 0.5×	60	1.3k
Daniel W. Beury United States	9	1.2k 1.9×	480 1.0×	853 2.2×	41 0.2×	135 0.7×	10	1.8k
Xiong Jin South Korea	20	148 0.2×	630 1.3×	299 0.8×	241 1.0×	79 0.4×	42	1.1k
Jacob A. Boyer United States	7	303 0.5×	440 0.9×	209 0.5×	49 0.2×	133 0.7×	9	1.1k

Countries citing papers authored by Aida Rashidi

Since Specialization

Citations

This map shows the geographic impact of Aida Rashidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aida Rashidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aida Rashidi more than expected).

Fields of papers citing papers by Aida Rashidi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aida Rashidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aida Rashidi. The network helps show where Aida Rashidi may publish in the future.

Co-authorship network of co-authors of Aida Rashidi

This figure shows the co-authorship network connecting the top 25 collaborators of Aida Rashidi. A scholar is included among the top collaborators of Aida Rashidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aida Rashidi. Aida Rashidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Peng, Aida Rashidi, Junfei Zhao, et al.. (2023). STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Nature Communications. 14(1). 1610–1610. 139 indexed citations breakdown →

Fares, Jawad, Deepak Kanojia, Crismita Dmello, et al.. (2023). Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases. Journal of Clinical Investigation. 133(24). 14 indexed citations

Billingham, Leah K., Joshua S. Stoolman, Karthik Vasan, et al.. (2022). Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nature Immunology. 23(5). 692–704. 216 indexed citations breakdown →

Miska, Jason, Aida Rashidi, Catalina Lee-Chang, et al.. (2021). Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma. Science Advances. 7(8). 75 indexed citations

Cordero, Álex, Deepak Kanojia, Jawad Fares, et al.. (2021). Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer. Proceedings of the National Academy of Sciences. 119(1). 11 indexed citations

Hou, David, Brandyn Castro, Aida Rashidi, et al.. (2021). IMMU-36. B CELL-VACCINE ELICITS LONG TERM IMMUNITY AGAINST GLIOBLASTOMA VIA ACTIVATION AND DIFFERENTIATION OF TUMOR-SPECIFIC CD8+ MEMORY T CELLS. Neuro-Oncology. 23(Supplement_6). vi100–vi100. 1 indexed citations

Lee-Chang, Catalina, Jason Miska, David Hou, et al.. (2020). Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma. The Journal of Experimental Medicine. 218(1). 49 indexed citations

Fares, Jawad, Deepak Kanojia, Aida Rashidi, Ilya V. Ulasov, & Maciej S. Lesniak. (2020). Genes that Mediate Metastasis across the Blood–Brain Barrier. Trends in cancer. 6(8). 660–676. 33 indexed citations

Fares, Jawad, Deepak Kanojia, Aida Rashidi, Ilya V. Ulasov, & Maciej S. Lesniak. (2020). Landscape of combination therapy trials in breast cancer brain metastasis. International Journal of Cancer. 147(7). 1939–1952. 33 indexed citations

10.

Lee-Chang, Catalina, Aida Rashidi, Jason Miska, et al.. (2019). Myeloid-Derived Suppressive Cells Promote B cell–Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma. Cancer Immunology Research. 7(12). 1928–1943. 120 indexed citations

11.

Miska, Jason, Catalina Lee-Chang, Aida Rashidi, et al.. (2019). HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma. Cell Reports. 27(1). 226–237.e4. 230 indexed citations

12.

Fares, Jawad, Deepak Kanojia, Aida Rashidi, et al.. (2019). Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations. Clinical Breast Cancer. 19(6). 383–391. 22 indexed citations

13.

Rashidi, Aida, Jason Miska, Catalina Lee-Chang, et al.. (2019). GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma. Cancer Immunology Immunotherapy. 69(1). 81–94. 40 indexed citations

14.

Kim, Julius W., J. Robert Kane, Wojciech K. Panek, et al.. (2018). A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics. 15(4). 1127–1138. 21 indexed citations

15.

Panek, Wojciech K., Katarzyna C. Pituch, Jason Miska, et al.. (2018). Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model. Molecular Neurobiology. 56(7). 5032–5040. 18 indexed citations

16.

Wu, Congyu, Megan E. Muroski, Jason Miska, et al.. (2018). Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment. Nanomedicine Nanotechnology Biology and Medicine. 16. 126–137. 45 indexed citations

17.

Rashidi, Aida, Jason Miska, Catalina Lee-Chang, et al.. (2018). IMMU-06. ABSENCE OF THE AMINO ACID STRESS-SENSOR GCN2 REDUCES SUPPRESSIVE EFFECTS OF MDSCs IN GLIOMA. Neuro-Oncology. 20(suppl_6). vi122–vi122. 1 indexed citations

18.

Muroski, Megan E., Jason Miska, Alan L. Chang, et al.. (2017). Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate. Scientific Reports. 7(1). 5790–5790. 26 indexed citations

19.

Kim, Julius W., Jason Miska, Jacob S. Young, et al.. (2017). A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model. Molecular Therapy — Oncolytics. 5. 97–104. 16 indexed citations

20.

Miska, Jason, Aida Rashidi, Alan L. Chang, et al.. (2016). Anti-GITR therapy promotes immunity against malignant glioma in a murine model. Cancer Immunology Immunotherapy. 65(12). 1555–1567. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact